# Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

> **NCT01519167** · PHASE4 · COMPLETED · sponsor: **Hospira, now a wholly owned subsidiary of Pfizer** · enrollment: 91 (actual)

## Conditions studied

- Ultrasound
- CT Scans
- MRIs

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT01519167
- **Lead sponsor:** Hospira, now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2017-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519167, "Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01519167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*